microRNA information: hsa-miR-149-5p
| Section | ID | link |
|---|---|---|
| Mature name: | hsa-miR-149-5p | miRbase |
| Accession: | MIMAT0000450 | miRbase |
| Precursor name: | hsa-mir-149 | miRbase |
| Precursor accession: | MI0000478 | miRbase |
| Symbol: | MIR149 | HGNC |
| RefSeq ID: | NR_029702 | GenBank |
| Sequence: | UCUGGCUCCGUGUCUUCACUCCC |
Reported expression in cancers: hsa-miR-149-5p
| miRNA | cancer | regulation | reporting | PUBMED | method |
|---|---|---|---|---|---|
| hsa-miR-149-5p | colorectal cancer | downregulation | "The DNA methylation status of the candidate miRNA ......" | 22821729 | RNA-Seq; qPCR |
| hsa-miR-149-5p | colorectal cancer | upregulation | "Furthermore it often translates to an increased ex ......" | 23115050 | |
| hsa-miR-149-5p | head and neck cancer | downregulation | "The association between genetic polymorphism and t ......" | 23272122 | |
| hsa-miR-149-5p | kidney renal cell cancer | downregulation | "Tumor suppressor miR 149 5p is associated with cel ......" | 27121091 | Microarray; qPCR |
| hsa-miR-149-5p | liver cancer | downregulation | "Then re-expression of miR-149 significantly inhibi ......" | 25424347 | |
| hsa-miR-149-5p | liver cancer | downregulation | "Although an increasing body of evidence indicates ......" | 26498692 | |
| hsa-miR-149-5p | prostate cancer | deregulation | "This study aimed to investigate the microRNA miRNA ......" | 19676045 | qPCR; Microarray |
Reported cancer pathway affected by hsa-miR-149-5p
| miRNA | cancer | pathway | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-149-5p | colorectal cancer | Apoptosis pathway | "MicroRNA 149 Increases the Sensitivity of Colorect ......" | 27415661 | Luciferase |
| hsa-miR-149-5p | gastric cancer | cell cycle pathway | "MicroRNA 149 inhibits proliferation and cell cycle ......" | 23144691 | |
| hsa-miR-149-5p | kidney renal cell cancer | Apoptosis pathway | "Tumor suppressor miR 149 5p is associated with cel ......" | 27121091 | Wound Healing Assay |
| hsa-miR-149-5p | prostate cancer | Apoptosis pathway | "We applied flow cytometry sorting of side populati ......" | 27573045 | Flow cytometry; Colony formation |
Reported cancer prognosis affected by hsa-miR-149-5p
| miRNA | cancer | prognosis | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-149-5p | breast cancer | metastasis; staging; cell migration | "MicroRNA 149 targets GIT1 to suppress integrin sig ......" | 24608434 | |
| hsa-miR-149-5p | breast cancer | recurrence | "Using microarray-based technology we have performe ......" | 24632820 | |
| hsa-miR-149-5p | breast cancer | drug resistance | "Methylation regulated miR 149 modulates chemoresis ......" | 25156775 | |
| hsa-miR-149-5p | breast cancer | worse prognosis; drug resistance | "The aim of this study was to investigate the role ......" | 27746365 | |
| hsa-miR-149-5p | colorectal cancer | poor survival | "SP1 mediates the link between methylation of the t ......" | 22821729 | |
| hsa-miR-149-5p | colorectal cancer | cell migration; progression; staging; metastasis; worse prognosis | "MicroRNA 149 suppresses colorectal cancer cell mig ......" | 25613903 | |
| hsa-miR-149-5p | colorectal cancer | drug resistance | "MicroRNA 149 Increases the Sensitivity of Colorect ......" | 27415661 | Luciferase |
| hsa-miR-149-5p | gastric cancer | progression; differentiation | "MicroRNA 149 inhibits proliferation and cell cycle ......" | 23144691 | |
| hsa-miR-149-5p | gastric cancer | worse prognosis | "The aim of the study was to investigated whether t ......" | 24379078 | |
| hsa-miR-149-5p | head and neck cancer | worse prognosis; poor survival; progression | "The association between genetic polymorphism and t ......" | 23272122 | |
| hsa-miR-149-5p | kidney renal cell cancer | staging; poor survival | "We genotyped four common miRNA SNPs i.e miR-146a r ......" | 24681820 | |
| hsa-miR-149-5p | liver cancer | worse prognosis; tumorigenesis | "Comprehensive analysis of microRNA regulated prote ......" | 25424347 | Luciferase |
| hsa-miR-149-5p | liver cancer | metastasis; progression; staging; worse prognosis; poor survival | "miR 149 represses metastasis of hepatocellular car ......" | 26498692 | |
| hsa-miR-149-5p | liver cancer | metastasis; poor survival; worse prognosis | "The clinicopathological significance of miR 149 an ......" | 27300349 | Western blot |
| hsa-miR-149-5p | lung squamous cell cancer | progression; poor survival; drug resistance | "A two miRNA signature miR-149 and miR-375 was foun ......" | 24007627 | |
| hsa-miR-149-5p | lymphoma | poor survival | "Among the 13 SNPs four DROSHA rs6877842 DICER rs37 ......" | 24563077 | |
| hsa-miR-149-5p | prostate cancer | drug resistance | "In this study we examined the expression of miRNA- ......" | 25462564 | Cell Proliferation Assay |
Reported gene related to hsa-miR-149-5p
| miRNA | cancer | gene | reporting | PUBMED |
|---|---|---|---|---|
| hsa-miR-149-5p | colorectal cancer | FOXM1 | "MicroRNA 149 suppresses colorectal cancer cell mig ......" | 25613903 |
| hsa-miR-149-5p | colorectal cancer | FOXM1 | "MicroRNA 149 Increases the Sensitivity of Colorect ......" | 27415661 |
| hsa-miR-149-5p | lung squamous cell cancer | FOXM1 | "miR 149 Inhibits Non Small Cell Lung Cancer Cells ......" | 23762558 |
| hsa-miR-149-5p | liver cancer | AKT1 | "We further observed that tumor tissues in patients ......" | 26550305 |
| hsa-miR-149-5p | breast cancer | GIT1 | "MicroRNA 149 targets GIT1 to suppress integrin sig ......" | 24608434 |
| hsa-miR-149-5p | breast cancer | GPC1 | "Downregulation of miR-149 was related to hypermeth ......" | 25156775 |
| hsa-miR-149-5p | breast cancer | ITGA9 | "MicroRNA 149 targets GIT1 to suppress integrin sig ......" | 24608434 |
| hsa-miR-149-5p | head and neck cancer | MMP8 | "Odds ratios ORs with 95% confidence interval CIs w ......" | 26277865 |
| hsa-miR-149-5p | liver cancer | MTOR | "Comprehensive analysis of microRNA regulated prote ......" | 25424347 |
| hsa-miR-149-5p | prostate cancer | NANOG | "The expression levels of SOX2 NANOG Oct4 miR-126 a ......" | 25462564 |
| hsa-miR-149-5p | breast cancer | NDST1 | "Furthermore we found that miR-149 modulated chemor ......" | 25156775 |
| hsa-miR-149-5p | liver cancer | PARP1 | "Increased PARP-1 and decreased miR-149 expression ......" | 27300349 |
| hsa-miR-149-5p | liver cancer | PARP2 | "The clinicopathological significance of miR 149 an ......" | 27300349 |
| hsa-miR-149-5p | liver cancer | PPM1F | "miR 149 represses metastasis of hepatocellular car ......" | 26498692 |
| hsa-miR-149-5p | breast cancer | PXN | "Expression of miR-149 impaired fibronectin-induced ......" | 24608434 |
| hsa-miR-149-5p | glioblastoma | RAP1B | "miR 128 and miR 149 enhance the chemosensitivity o ......" | 25017996 |
| hsa-miR-149-5p | prostate cancer | SDC1 | "In this study we examined the expression of miRNA- ......" | 25462564 |
| hsa-miR-149-5p | prostate cancer | SOX2 | "The expression levels of SOX2 NANOG Oct4 miR-126 a ......" | 25462564 |
| hsa-miR-149-5p | colorectal cancer | SP1 | "SP1 mediates the link between methylation of the t ......" | 22821729 |
| hsa-miR-149-5p | colorectal cancer | SRPX2 | "Non CpG island promoter hypomethylation and miR 14 ......" | 23115050 |
| hsa-miR-149-5p | gastric cancer | ZBTB2 | "MicroRNA 149 inhibits proliferation and cell cycle ......" | 23144691 |
Expression profile in cancer corhorts:
Putative target regulations
| miRNA | Gene | Cancer | Interaction | Correlation beta |
|---|---|---|---|---|
hsa-miR-149-5p | AKAP13 | 13 cancers: BLCA; CESC; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.143; TCGA CESC -0.082; TCGA ESCA -0.129; TCGA HNSC -0.083; TCGA KIRC -0.124; TCGA LGG -0.091; TCGA LUAD -0.086; TCGA LUSC -0.172; TCGA PAAD -0.127; TCGA PRAD -0.143; TCGA SARC -0.076; TCGA THCA -0.078; TCGA UCEC -0.129 |
hsa-miR-149-5p | CALD1 | 10 cancers: BLCA; BRCA; HNSC; KIRC; LIHC; LUSC; PRAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.386; TCGA BRCA -0.065; TCGA HNSC -0.256; TCGA KIRC -0.074; TCGA LIHC -0.065; TCGA LUSC -0.191; TCGA PRAD -0.16; TCGA SARC -0.208; TCGA THCA -0.104; TCGA UCEC -0.23 |
hsa-miR-149-5p | EEF1B2 | 9 cancers: BLCA; BRCA; ESCA; KIRC; LGG; LIHC; LUAD; PRAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.056; TCGA BRCA -0.071; TCGA ESCA -0.061; TCGA KIRC -0.06; TCGA LGG -0.153; TCGA LIHC -0.051; TCGA LUAD -0.101; TCGA PRAD -0.076; TCGA UCEC -0.085 |
hsa-miR-149-5p | EIF4B | 9 cancers: BLCA; KIRC; LGG; LIHC; LUAD; PAAD; PRAD; THCA; UCEC | miRNAWalker2 validate; miRNATAP | TCGA BLCA -0.064; TCGA KIRC -0.086; TCGA LGG -0.165; TCGA LIHC -0.053; TCGA LUAD -0.1; TCGA PAAD -0.071; TCGA PRAD -0.09; TCGA THCA -0.094; TCGA UCEC -0.086 |
hsa-miR-149-5p | ETS2 | 11 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.08; TCGA BRCA -0.129; TCGA ESCA -0.062; TCGA HNSC -0.117; TCGA KIRC -0.097; TCGA LUAD -0.098; TCGA LUSC -0.075; TCGA PRAD -0.098; TCGA SARC -0.117; TCGA STAD -0.088; TCGA UCEC -0.173 |
hsa-miR-149-5p | GOLIM4 | 9 cancers: BLCA; KIRC; KIRP; LGG; LIHC; PAAD; PRAD; SARC; THCA | miRNAWalker2 validate | TCGA BLCA -0.082; TCGA KIRC -0.071; TCGA KIRP -0.14; TCGA LGG -0.178; TCGA LIHC -0.122; TCGA PAAD -0.179; TCGA PRAD -0.251; TCGA SARC -0.139; TCGA THCA -0.152 |
hsa-miR-149-5p | HIPK2 | 11 cancers: BLCA; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; THCA | miRNAWalker2 validate; miRNATAP | TCGA BLCA -0.119; TCGA ESCA -0.101; TCGA HNSC -0.054; TCGA KIRC -0.1; TCGA KIRP -0.142; TCGA LGG -0.061; TCGA LIHC -0.115; TCGA LUAD -0.054; TCGA LUSC -0.115; TCGA PRAD -0.113; TCGA THCA -0.079 |
hsa-miR-149-5p | IFI30 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUSC; OV; SARC | miRNAWalker2 validate | TCGA BLCA -0.243; TCGA BRCA -0.084; TCGA COAD -0.166; TCGA ESCA -0.136; TCGA HNSC -0.188; TCGA KIRC -0.124; TCGA KIRP -0.222; TCGA LGG -0.132; TCGA LUSC -0.342; TCGA OV -0.216; TCGA SARC -0.134 |
hsa-miR-149-5p | KIAA1462 | 9 cancers: BLCA; ESCA; HNSC; KIRC; LUSC; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.221; TCGA ESCA -0.196; TCGA HNSC -0.206; TCGA KIRC -0.086; TCGA LUSC -0.442; TCGA PRAD -0.172; TCGA SARC -0.105; TCGA STAD -0.085; TCGA UCEC -0.213 |
hsa-miR-149-5p | LRIG1 | 12 cancers: BLCA; CESC; ESCA; KIRC; KIRP; LGG; LIHC; LUAD; PAAD; PRAD; SARC; THCA | miRNAWalker2 validate | TCGA BLCA -0.431; TCGA CESC -0.165; TCGA ESCA -0.131; TCGA KIRC -0.079; TCGA KIRP -0.148; TCGA LGG -0.252; TCGA LIHC -0.082; TCGA LUAD -0.065; TCGA PAAD -0.109; TCGA PRAD -0.067; TCGA SARC -0.091; TCGA THCA -0.075 |
hsa-miR-149-5p | NFIX | 9 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; PAAD | miRNAWalker2 validate; MirTarget | TCGA BLCA -0.313; TCGA BRCA -0.201; TCGA HNSC -0.066; TCGA KIRC -0.127; TCGA KIRP -0.093; TCGA LGG -0.15; TCGA LIHC -0.102; TCGA LUSC -0.174; TCGA PAAD -0.109 |
hsa-miR-149-5p | OSBPL8 | 9 cancers: BLCA; COAD; HNSC; KIRP; LGG; LUAD; PRAD; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.074; TCGA COAD -0.082; TCGA HNSC -0.068; TCGA KIRP -0.062; TCGA LGG -0.132; TCGA LUAD -0.052; TCGA PRAD -0.175; TCGA THCA -0.116; TCGA UCEC -0.061 |
hsa-miR-149-5p | SERINC1 | 11 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LIHC; LUSC; PRAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.082; TCGA COAD -0.051; TCGA ESCA -0.069; TCGA HNSC -0.083; TCGA KIRP -0.116; TCGA LIHC -0.053; TCGA LUSC -0.15; TCGA PRAD -0.104; TCGA SARC -0.067; TCGA THCA -0.059; TCGA UCEC -0.104 |
hsa-miR-149-5p | USP15 | 9 cancers: BLCA; COAD; HNSC; KIRC; OV; PAAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.052; TCGA COAD -0.079; TCGA HNSC -0.09; TCGA KIRC -0.075; TCGA OV -0.055; TCGA PAAD -0.076; TCGA SARC -0.069; TCGA STAD -0.071; TCGA UCEC -0.062 |
hsa-miR-149-5p | SOAT1 | 14 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LGG; LUAD; LUSC; OV; PRAD; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.07; TCGA BRCA -0.051; TCGA CESC -0.07; TCGA COAD -0.128; TCGA HNSC -0.139; TCGA KIRP -0.199; TCGA LGG -0.076; TCGA LUAD -0.066; TCGA LUSC -0.129; TCGA OV -0.068; TCGA PRAD -0.102; TCGA SARC -0.092; TCGA THCA -0.113; TCGA UCEC -0.17 |
hsa-miR-149-5p | SAMD4A | 10 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; LGG; LIHC; LUSC; PRAD; SARC | MirTarget | TCGA BLCA -0.295; TCGA BRCA -0.133; TCGA ESCA -0.142; TCGA HNSC -0.197; TCGA KIRC -0.094; TCGA LGG -0.06; TCGA LIHC -0.08; TCGA LUSC -0.329; TCGA PRAD -0.132; TCGA SARC -0.118 |
hsa-miR-149-5p | CSF1 | 13 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LGG; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.373; TCGA BRCA -0.144; TCGA HNSC -0.347; TCGA KIRC -0.135; TCGA KIRP -0.11; TCGA LGG -0.106; TCGA LUSC -0.237; TCGA OV -0.19; TCGA PRAD -0.148; TCGA SARC -0.26; TCGA THCA -0.167; TCGA STAD -0.06; TCGA UCEC -0.122 |
hsa-miR-149-5p | ARHGAP26 | 13 cancers: BLCA; BRCA; CESC; ESCA; KIRC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.119; TCGA BRCA -0.121; TCGA CESC -0.247; TCGA ESCA -0.36; TCGA KIRC -0.223; TCGA LUAD -0.204; TCGA LUSC -0.092; TCGA OV -0.2; TCGA PAAD -0.152; TCGA PRAD -0.147; TCGA THCA -0.076; TCGA STAD -0.106; TCGA UCEC -0.24 |
hsa-miR-149-5p | ADAMDEC1 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; OV; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.335; TCGA BRCA -0.126; TCGA COAD -0.216; TCGA ESCA -0.139; TCGA HNSC -0.323; TCGA KIRC -0.764; TCGA KIRP -0.33; TCGA LGG -0.435; TCGA OV -0.442; TCGA PAAD -0.35; TCGA PRAD -0.21; TCGA SARC -0.365; TCGA THCA -0.315; TCGA STAD -0.318 |
hsa-miR-149-5p | ROR1 | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LUSC; PRAD; SARC; THCA | MirTarget; miRNATAP | TCGA BLCA -0.432; TCGA BRCA -0.16; TCGA CESC -0.21; TCGA ESCA -0.294; TCGA HNSC -0.38; TCGA KIRC -0.105; TCGA KIRP -0.208; TCGA LUSC -0.647; TCGA PRAD -0.564; TCGA SARC -0.216; TCGA THCA -0.257 |
hsa-miR-149-5p | GALNT10 | 9 cancers: BLCA; CESC; ESCA; HNSC; LGG; LUAD; LUSC; PRAD; STAD | MirTarget | TCGA BLCA -0.174; TCGA CESC -0.155; TCGA ESCA -0.198; TCGA HNSC -0.195; TCGA LGG -0.101; TCGA LUAD -0.074; TCGA LUSC -0.205; TCGA PRAD -0.129; TCGA STAD -0.07 |
hsa-miR-149-5p | RAB37 | 9 cancers: BLCA; CESC; ESCA; KIRC; KIRP; LIHC; LUAD; LUSC; UCEC | MirTarget | TCGA BLCA -0.282; TCGA CESC -0.202; TCGA ESCA -0.412; TCGA KIRC -0.338; TCGA KIRP -0.208; TCGA LIHC -0.173; TCGA LUAD -0.14; TCGA LUSC -0.38; TCGA UCEC -0.207 |
hsa-miR-149-5p | PODXL | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.108; TCGA BRCA -0.097; TCGA CESC -0.189; TCGA ESCA -0.275; TCGA HNSC -0.083; TCGA LUSC -0.316; TCGA PRAD -0.16; TCGA SARC -0.127; TCGA STAD -0.079; TCGA UCEC -0.175 |
hsa-miR-149-5p | CSGALNACT2 | 9 cancers: BLCA; COAD; HNSC; KIRC; LGG; LUSC; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.134; TCGA COAD -0.085; TCGA HNSC -0.137; TCGA KIRC -0.143; TCGA LGG -0.118; TCGA LUSC -0.149; TCGA PRAD -0.115; TCGA STAD -0.071; TCGA UCEC -0.062 |
hsa-miR-149-5p | PXK | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LUSC; OV; PAAD; PRAD; SARC; THCA | MirTarget | TCGA BLCA -0.154; TCGA CESC -0.127; TCGA COAD -0.082; TCGA ESCA -0.087; TCGA HNSC -0.149; TCGA KIRP -0.159; TCGA LUSC -0.168; TCGA OV -0.073; TCGA PAAD -0.12; TCGA PRAD -0.23; TCGA SARC -0.178; TCGA THCA -0.25 |
hsa-miR-149-5p | RAP1A | 10 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LUSC; PAAD; PRAD; SARC; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.106; TCGA COAD -0.051; TCGA ESCA -0.058; TCGA HNSC -0.091; TCGA KIRP -0.067; TCGA LUSC -0.139; TCGA PAAD -0.071; TCGA PRAD -0.091; TCGA SARC -0.196; TCGA UCEC -0.094 |
hsa-miR-149-5p | CACNA1C | 9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUSC; PAAD; PRAD; UCEC | MirTarget | TCGA BLCA -0.301; TCGA BRCA -0.06; TCGA CESC -0.181; TCGA ESCA -0.175; TCGA HNSC -0.172; TCGA LUSC -0.347; TCGA PAAD -0.292; TCGA PRAD -0.224; TCGA UCEC -0.215 |
hsa-miR-149-5p | CD93 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.218; TCGA BRCA -0.069; TCGA CESC -0.136; TCGA COAD -0.198; TCGA ESCA -0.258; TCGA HNSC -0.22; TCGA KIRC -0.154; TCGA LGG -0.229; TCGA LUAD -0.061; TCGA LUSC -0.462; TCGA PAAD -0.131; TCGA PRAD -0.161; TCGA SARC -0.16; TCGA STAD -0.099; TCGA UCEC -0.206 |
hsa-miR-149-5p | SLAMF7 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LGG; LUSC; OV; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.223; TCGA BRCA -0.173; TCGA COAD -0.388; TCGA ESCA -0.165; TCGA HNSC -0.325; TCGA KIRC -0.498; TCGA LGG -0.173; TCGA LUSC -0.26; TCGA OV -0.396; TCGA SARC -0.418; TCGA THCA -0.213; TCGA STAD -0.182; TCGA UCEC -0.23 |
hsa-miR-149-5p | ST8SIA4 | 11 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LUSC; OV; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.177; TCGA BRCA -0.073; TCGA CESC -0.091; TCGA COAD -0.238; TCGA HNSC -0.173; TCGA KIRC -0.606; TCGA LUSC -0.254; TCGA OV -0.119; TCGA PRAD -0.171; TCGA STAD -0.157; TCGA UCEC -0.146 |
hsa-miR-149-5p | TCF12 | 10 cancers: BLCA; CESC; ESCA; HNSC; LGG; LUAD; PAAD; PRAD; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.06; TCGA CESC -0.083; TCGA ESCA -0.057; TCGA HNSC -0.063; TCGA LGG -0.386; TCGA LUAD -0.056; TCGA PAAD -0.132; TCGA PRAD -0.168; TCGA THCA -0.053; TCGA STAD -0.063 |
hsa-miR-149-5p | GLIPR1 | 10 cancers: BLCA; BRCA; HNSC; KIRC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.354; TCGA BRCA -0.116; TCGA HNSC -0.299; TCGA KIRC -0.201; TCGA LUAD -0.056; TCGA LUSC -0.262; TCGA PRAD -0.157; TCGA SARC -0.143; TCGA STAD -0.076; TCGA UCEC -0.231 |
hsa-miR-149-5p | PDGFRA | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LUSC; PAAD; PRAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.266; TCGA BRCA -0.102; TCGA CESC -0.152; TCGA ESCA -0.205; TCGA HNSC -0.174; TCGA LGG -0.251; TCGA LUSC -0.289; TCGA PAAD -0.296; TCGA PRAD -0.269; TCGA UCEC -0.157 |
hsa-miR-149-5p | SDCBP | 10 cancers: BLCA; ESCA; HNSC; KIRP; LIHC; LUSC; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.094; TCGA ESCA -0.114; TCGA HNSC -0.078; TCGA KIRP -0.126; TCGA LIHC -0.062; TCGA LUSC -0.176; TCGA PAAD -0.107; TCGA THCA -0.091; TCGA STAD -0.052; TCGA UCEC -0.075 |
hsa-miR-149-5p | CREBL2 | 11 cancers: BLCA; CESC; HNSC; KIRP; LIHC; LUAD; LUSC; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.094; TCGA CESC -0.059; TCGA HNSC -0.063; TCGA KIRP -0.091; TCGA LIHC -0.062; TCGA LUAD -0.096; TCGA LUSC -0.133; TCGA SARC -0.092; TCGA THCA -0.058; TCGA STAD -0.1; TCGA UCEC -0.134 |
hsa-miR-149-5p | TRIM44 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PRAD; THCA | MirTarget | TCGA BLCA -0.112; TCGA CESC -0.066; TCGA COAD -0.064; TCGA ESCA -0.079; TCGA HNSC -0.144; TCGA KIRP -0.154; TCGA LUAD -0.057; TCGA LUSC -0.072; TCGA PRAD -0.242; TCGA THCA -0.204 |
hsa-miR-149-5p | PIK3R6 | 11 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LUSC; OV; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.285; TCGA BRCA -0.102; TCGA COAD -0.164; TCGA HNSC -0.215; TCGA KIRC -0.516; TCGA KIRP -0.232; TCGA LUSC -0.311; TCGA OV -0.161; TCGA SARC -0.137; TCGA STAD -0.145; TCGA UCEC -0.125 |
hsa-miR-149-5p | GRAMD1B | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD | mirMAP | TCGA BLCA -0.248; TCGA BRCA -0.201; TCGA CESC -0.472; TCGA ESCA -0.733; TCGA HNSC -0.294; TCGA KIRP -0.202; TCGA LUAD -0.133; TCGA LUSC -0.348; TCGA PAAD -0.418; TCGA PRAD -0.248 |
hsa-miR-149-5p | FAM168A | 9 cancers: BLCA; CESC; COAD; HNSC; KIRP; LGG; LUSC; PRAD; THCA | mirMAP | TCGA BLCA -0.08; TCGA CESC -0.081; TCGA COAD -0.1; TCGA HNSC -0.102; TCGA KIRP -0.12; TCGA LGG -0.078; TCGA LUSC -0.06; TCGA PRAD -0.264; TCGA THCA -0.207 |
hsa-miR-149-5p | MGLL | 12 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; UCEC | mirMAP | TCGA BLCA -0.22; TCGA CESC -0.126; TCGA ESCA -0.287; TCGA HNSC -0.134; TCGA KIRC -0.09; TCGA KIRP -0.127; TCGA LUAD -0.086; TCGA LUSC -0.281; TCGA PAAD -0.147; TCGA PRAD -0.179; TCGA SARC -0.163; TCGA UCEC -0.175 |
hsa-miR-149-5p | TNS1 | 11 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LUSC; PAAD; PRAD; SARC; THCA; UCEC | mirMAP | TCGA BLCA -0.471; TCGA BRCA -0.064; TCGA HNSC -0.17; TCGA KIRC -0.078; TCGA KIRP -0.084; TCGA LUSC -0.331; TCGA PAAD -0.143; TCGA PRAD -0.227; TCGA SARC -0.276; TCGA THCA -0.056; TCGA UCEC -0.148 |
hsa-miR-149-5p | TSPAN11 | 9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LUAD; LUSC; PRAD | mirMAP | TCGA BLCA -0.292; TCGA BRCA -0.111; TCGA CESC -0.125; TCGA ESCA -0.141; TCGA HNSC -0.214; TCGA LGG -0.227; TCGA LUAD -0.112; TCGA LUSC -0.214; TCGA PRAD -0.198 |
hsa-miR-149-5p | USHBP1 | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LUSC; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.141; TCGA BRCA -0.141; TCGA CESC -0.189; TCGA ESCA -0.242; TCGA HNSC -0.103; TCGA KIRC -0.158; TCGA LUSC -0.505; TCGA SARC -0.112; TCGA STAD -0.114; TCGA UCEC -0.13 |
hsa-miR-149-5p | SLCO2B1 | 16 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.367; TCGA BRCA -0.131; TCGA ESCA -0.328; TCGA HNSC -0.39; TCGA KIRC -0.317; TCGA KIRP -0.268; TCGA LGG -0.068; TCGA LIHC -0.212; TCGA LUAD -0.095; TCGA LUSC -0.512; TCGA OV -0.196; TCGA PAAD -0.169; TCGA PRAD -0.118; TCGA SARC -0.239; TCGA STAD -0.111; TCGA UCEC -0.231 |
hsa-miR-149-5p | NFIC | 9 cancers: BLCA; HNSC; KIRP; LIHC; LUSC; PRAD; SARC; THCA; UCEC | mirMAP | TCGA BLCA -0.209; TCGA HNSC -0.134; TCGA KIRP -0.096; TCGA LIHC -0.095; TCGA LUSC -0.053; TCGA PRAD -0.196; TCGA SARC -0.197; TCGA THCA -0.168; TCGA UCEC -0.119 |
hsa-miR-149-5p | KIAA1755 | 9 cancers: BLCA; BRCA; ESCA; HNSC; LGG; LUSC; PRAD; SARC; UCEC | mirMAP | TCGA BLCA -0.442; TCGA BRCA -0.186; TCGA ESCA -0.126; TCGA HNSC -0.295; TCGA LGG -0.177; TCGA LUSC -0.235; TCGA PRAD -0.092; TCGA SARC -0.17; TCGA UCEC -0.222 |
hsa-miR-149-5p | SDC3 | 10 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LUSC; OV; PAAD; PRAD | mirMAP | TCGA BLCA -0.155; TCGA BRCA -0.085; TCGA CESC -0.083; TCGA HNSC -0.199; TCGA KIRC -0.098; TCGA KIRP -0.075; TCGA LUSC -0.143; TCGA OV -0.067; TCGA PAAD -0.125; TCGA PRAD -0.076 |
hsa-miR-149-5p | CIITA | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.307; TCGA BRCA -0.212; TCGA CESC -0.297; TCGA COAD -0.258; TCGA ESCA -0.317; TCGA HNSC -0.369; TCGA KIRC -0.256; TCGA KIRP -0.154; TCGA LUAD -0.072; TCGA LUSC -0.432; TCGA OV -0.37; TCGA PRAD -0.099; TCGA SARC -0.322; TCGA THCA -0.172; TCGA STAD -0.289; TCGA UCEC -0.258 |
hsa-miR-149-5p | GIPC3 | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUSC; UCEC | mirMAP | TCGA BLCA -0.07; TCGA CESC -0.176; TCGA COAD -0.1; TCGA ESCA -0.171; TCGA HNSC -0.118; TCGA KIRC -0.172; TCGA LGG -0.079; TCGA LUSC -0.316; TCGA UCEC -0.121 |
hsa-miR-149-5p | LRP10 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUSC; SARC; THCA | mirMAP | TCGA BLCA -0.057; TCGA CESC -0.082; TCGA COAD -0.089; TCGA ESCA -0.099; TCGA HNSC -0.09; TCGA KIRP -0.062; TCGA LGG -0.058; TCGA LUSC -0.085; TCGA SARC -0.101; TCGA THCA -0.084 |
hsa-miR-149-5p | SPN | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.336; TCGA BRCA -0.151; TCGA CESC -0.151; TCGA COAD -0.173; TCGA ESCA -0.147; TCGA HNSC -0.319; TCGA KIRC -0.447; TCGA KIRP -0.175; TCGA LUAD -0.103; TCGA LUSC -0.567; TCGA OV -0.185; TCGA PRAD -0.101; TCGA SARC -0.319; TCGA THCA -0.122; TCGA STAD -0.121; TCGA UCEC -0.223 |
hsa-miR-149-5p | MBP | 12 cancers: BLCA; BRCA; HNSC; KIRP; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.066; TCGA BRCA -0.092; TCGA HNSC -0.128; TCGA KIRP -0.144; TCGA LUAD -0.079; TCGA LUSC -0.101; TCGA OV -0.133; TCGA PRAD -0.053; TCGA SARC -0.293; TCGA THCA -0.127; TCGA STAD -0.051; TCGA UCEC -0.125 |
hsa-miR-149-5p | NFIB | 11 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LGG; LUSC; PAAD; PRAD; STAD | miRNATAP | TCGA BLCA -0.181; TCGA BRCA -0.166; TCGA ESCA -0.121; TCGA HNSC -0.097; TCGA KIRC -0.101; TCGA KIRP -0.068; TCGA LGG -0.208; TCGA LUSC -0.165; TCGA PAAD -0.215; TCGA PRAD -0.073; TCGA STAD -0.119 |
hsa-miR-149-5p | KDR | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LIHC; LUSC; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.096; TCGA CESC -0.168; TCGA COAD -0.177; TCGA ESCA -0.22; TCGA HNSC -0.163; TCGA KIRC -0.285; TCGA LGG -0.14; TCGA LIHC -0.162; TCGA LUSC -0.415; TCGA PRAD -0.186; TCGA SARC -0.088; TCGA STAD -0.085; TCGA UCEC -0.245 |
hsa-miR-149-5p | LOX | 9 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LUSC; PRAD; SARC; THCA | miRNATAP | TCGA BLCA -0.25; TCGA BRCA -0.072; TCGA COAD -0.166; TCGA HNSC -0.169; TCGA KIRC -0.518; TCGA LUSC -0.1; TCGA PRAD -0.28; TCGA SARC -0.134; TCGA THCA -0.21 |
hsa-miR-149-5p | ADAMTS6 | 9 cancers: BLCA; CESC; ESCA; HNSC; LGG; LUSC; PRAD; SARC; UCEC | miRNATAP | TCGA BLCA -0.284; TCGA CESC -0.178; TCGA ESCA -0.117; TCGA HNSC -0.192; TCGA LGG -0.367; TCGA LUSC -0.282; TCGA PRAD -0.121; TCGA SARC -0.103; TCGA UCEC -0.154 |
hsa-miR-149-5p | SETD7 | 13 cancers: BLCA; COAD; HNSC; KIRC; LGG; LIHC; LUSC; OV; PAAD; PRAD; SARC; THCA; UCEC | miRNATAP | TCGA BLCA -0.116; TCGA COAD -0.101; TCGA HNSC -0.069; TCGA KIRC -0.133; TCGA LGG -0.113; TCGA LIHC -0.105; TCGA LUSC -0.065; TCGA OV -0.088; TCGA PAAD -0.114; TCGA PRAD -0.078; TCGA SARC -0.178; TCGA THCA -0.134; TCGA UCEC -0.305 |
hsa-miR-149-5p | DAB2 | 14 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.139; TCGA BRCA -0.057; TCGA CESC -0.088; TCGA ESCA -0.115; TCGA HNSC -0.294; TCGA KIRC -0.185; TCGA KIRP -0.166; TCGA LGG -0.192; TCGA LUAD -0.067; TCGA LUSC -0.274; TCGA PRAD -0.127; TCGA SARC -0.149; TCGA STAD -0.094; TCGA UCEC -0.245 |
hsa-miR-149-5p | SIRPB2 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUSC; OV; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.227; TCGA BRCA -0.104; TCGA COAD -0.251; TCGA ESCA -0.161; TCGA HNSC -0.274; TCGA KIRC -0.429; TCGA KIRP -0.181; TCGA LUSC -0.46; TCGA OV -0.233; TCGA PRAD -0.154; TCGA SARC -0.247; TCGA STAD -0.148; TCGA UCEC -0.157 |
hsa-miR-149-5p | TPP1 | 12 cancers: BLCA; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; THCA; UCEC | miRNATAP | TCGA BLCA -0.108; TCGA ESCA -0.079; TCGA HNSC -0.155; TCGA KIRC -0.159; TCGA KIRP -0.187; TCGA LIHC -0.066; TCGA LUAD -0.056; TCGA LUSC -0.165; TCGA PRAD -0.074; TCGA SARC -0.146; TCGA THCA -0.086; TCGA UCEC -0.059 |
hsa-miR-149-5p | PRKG1 | 9 cancers: BLCA; CESC; COAD; HNSC; LUSC; PAAD; PRAD; SARC; UCEC | miRNATAP | TCGA BLCA -0.428; TCGA CESC -0.184; TCGA COAD -0.268; TCGA HNSC -0.274; TCGA LUSC -0.337; TCGA PAAD -0.238; TCGA PRAD -0.529; TCGA SARC -0.3; TCGA UCEC -0.329 |
hsa-miR-149-5p | RCAN2 | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUAD; LUSC; PRAD; SARC; UCEC | miRNATAP | TCGA BLCA -0.361; TCGA BRCA -0.051; TCGA CESC -0.179; TCGA ESCA -0.175; TCGA HNSC -0.304; TCGA LUAD -0.083; TCGA LUSC -0.406; TCGA PRAD -0.141; TCGA SARC -0.118; TCGA UCEC -0.123 |
hsa-miR-149-5p | FZD5 | 10 cancers: BRCA; CESC; ESCA; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA | miRNAWalker2 validate; miRNATAP | TCGA BRCA -0.062; TCGA CESC -0.086; TCGA ESCA -0.406; TCGA KIRC -0.196; TCGA KIRP -0.072; TCGA LUAD -0.052; TCGA LUSC -0.107; TCGA PAAD -0.148; TCGA PRAD -0.072; TCGA THCA -0.133 |
hsa-miR-149-5p | PTPRK | 9 cancers: BRCA; CESC; ESCA; HNSC; KIRC; KIRP; PRAD; SARC; STAD | miRNAWalker2 validate; miRNATAP | TCGA BRCA -0.066; TCGA CESC -0.055; TCGA ESCA -0.107; TCGA HNSC -0.075; TCGA KIRC -0.077; TCGA KIRP -0.073; TCGA PRAD -0.175; TCGA SARC -0.066; TCGA STAD -0.057 |
hsa-miR-149-5p | PAG1 | 10 cancers: BRCA; ESCA; HNSC; KIRC; LGG; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.053; TCGA ESCA -0.268; TCGA HNSC -0.249; TCGA KIRC -0.303; TCGA LGG -0.204; TCGA LUSC -0.327; TCGA PRAD -0.129; TCGA SARC -0.155; TCGA STAD -0.118; TCGA UCEC -0.084 |
hsa-miR-149-5p | H6PD | 10 cancers: BRCA; CESC; HNSC; KIRC; KIRP; LIHC; OV; PRAD; STAD; UCEC | mirMAP | TCGA BRCA -0.085; TCGA CESC -0.101; TCGA HNSC -0.066; TCGA KIRC -0.089; TCGA KIRP -0.078; TCGA LIHC -0.115; TCGA OV -0.075; TCGA PRAD -0.076; TCGA STAD -0.07; TCGA UCEC -0.087 |
hsa-miR-149-5p | ATP11A | 10 cancers: BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; UCEC | mirMAP | TCGA BRCA -0.104; TCGA CESC -0.136; TCGA ESCA -0.228; TCGA HNSC -0.075; TCGA KIRC -0.347; TCGA KIRP -0.162; TCGA LUAD -0.094; TCGA LUSC -0.3; TCGA PRAD -0.199; TCGA UCEC -0.105 |
hsa-miR-149-5p | KIF21B | 11 cancers: BRCA; CESC; ESCA; HNSC; KIRC; LGG; LUSC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BRCA -0.118; TCGA CESC -0.236; TCGA ESCA -0.369; TCGA HNSC -0.215; TCGA KIRC -0.448; TCGA LGG -0.14; TCGA LUSC -0.339; TCGA PAAD -0.24; TCGA PRAD -0.172; TCGA THCA -0.126; TCGA STAD -0.087 |
hsa-miR-149-5p | PPARA | 9 cancers: BRCA; ESCA; KIRP; LIHC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BRCA -0.15; TCGA ESCA -0.09; TCGA KIRP -0.123; TCGA LIHC -0.179; TCGA PAAD -0.117; TCGA PRAD -0.135; TCGA SARC -0.105; TCGA THCA -0.17; TCGA STAD -0.069 |
hsa-miR-149-5p | SLC4A4 | 9 cancers: BRCA; CESC; ESCA; KIRP; LUAD; LUSC; SARC; STAD; UCEC | miRNATAP | TCGA BRCA -0.126; TCGA CESC -0.504; TCGA ESCA -0.934; TCGA KIRP -0.431; TCGA LUAD -0.136; TCGA LUSC -0.556; TCGA SARC -0.137; TCGA STAD -0.2; TCGA UCEC -0.238 |
hsa-miR-149-5p | MAN2A1 | 14 cancers: CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA CESC -0.137; TCGA COAD -0.103; TCGA ESCA -0.099; TCGA HNSC -0.195; TCGA KIRP -0.174; TCGA LIHC -0.112; TCGA LUAD -0.064; TCGA LUSC -0.104; TCGA OV -0.092; TCGA PRAD -0.372; TCGA SARC -0.241; TCGA THCA -0.157; TCGA STAD -0.093; TCGA UCEC -0.167 |
hsa-miR-149-5p | RAPGEF2 | 9 cancers: CESC; ESCA; HNSC; KIRC; LIHC; LUSC; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA CESC -0.11; TCGA ESCA -0.162; TCGA HNSC -0.131; TCGA KIRC -0.16; TCGA LIHC -0.121; TCGA LUSC -0.242; TCGA PRAD -0.103; TCGA STAD -0.077; TCGA UCEC -0.076 |
hsa-miR-149-5p | RB1 | 11 cancers: CESC; COAD; HNSC; KIRC; LGG; LIHC; LUAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA CESC -0.087; TCGA COAD -0.077; TCGA HNSC -0.079; TCGA KIRC -0.096; TCGA LGG -0.058; TCGA LIHC -0.086; TCGA LUAD -0.094; TCGA PRAD -0.112; TCGA THCA -0.059; TCGA STAD -0.141; TCGA UCEC -0.14 |
hsa-miR-149-5p | SEC23IP | 9 cancers: CESC; ESCA; HNSC; LGG; LIHC; PAAD; PRAD; THCA; UCEC | miRNAWalker2 validate | TCGA CESC -0.05; TCGA ESCA -0.145; TCGA HNSC -0.079; TCGA LGG -0.056; TCGA LIHC -0.053; TCGA PAAD -0.102; TCGA PRAD -0.097; TCGA THCA -0.076; TCGA UCEC -0.051 |
hsa-miR-149-5p | SMCR8 | 9 cancers: CESC; HNSC; KIRP; LGG; LUSC; PRAD; SARC; THCA; UCEC | miRNAWalker2 validate; MirTarget | TCGA CESC -0.069; TCGA HNSC -0.085; TCGA KIRP -0.121; TCGA LGG -0.066; TCGA LUSC -0.053; TCGA PRAD -0.112; TCGA SARC -0.114; TCGA THCA -0.116; TCGA UCEC -0.054 |
hsa-miR-149-5p | FLT1 | 10 cancers: CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; STAD; UCEC | MirTarget | TCGA CESC -0.083; TCGA COAD -0.158; TCGA ESCA -0.185; TCGA HNSC -0.075; TCGA KIRC -0.4; TCGA LIHC -0.09; TCGA LUAD -0.061; TCGA LUSC -0.201; TCGA STAD -0.067; TCGA UCEC -0.159 |
hsa-miR-149-5p | XPO4 | 10 cancers: CESC; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD | MirTarget | TCGA CESC -0.066; TCGA ESCA -0.055; TCGA HNSC -0.065; TCGA LGG -0.072; TCGA LUAD -0.062; TCGA LUSC -0.058; TCGA PAAD -0.075; TCGA PRAD -0.142; TCGA THCA -0.067; TCGA STAD -0.081 |
hsa-miR-149-5p | RALGAPA2 | 9 cancers: CESC; ESCA; HNSC; LUSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA CESC -0.244; TCGA ESCA -0.385; TCGA HNSC -0.082; TCGA LUSC -0.207; TCGA PRAD -0.277; TCGA SARC -0.095; TCGA THCA -0.153; TCGA STAD -0.093; TCGA UCEC -0.099 |
hsa-miR-149-5p | EPB41 | 10 cancers: CESC; ESCA; KIRC; KIRP; LGG; LUSC; OV; PRAD; THCA; STAD | MirTarget | TCGA CESC -0.059; TCGA ESCA -0.132; TCGA KIRC -0.108; TCGA KIRP -0.13; TCGA LGG -0.142; TCGA LUSC -0.074; TCGA OV -0.055; TCGA PRAD -0.111; TCGA THCA -0.065; TCGA STAD -0.059 |
hsa-miR-149-5p | SOCS6 | 9 cancers: COAD; ESCA; HNSC; KIRP; LIHC; LUAD; PRAD; THCA; UCEC | miRNATAP | TCGA COAD -0.079; TCGA ESCA -0.104; TCGA HNSC -0.078; TCGA KIRP -0.065; TCGA LIHC -0.081; TCGA LUAD -0.053; TCGA PRAD -0.106; TCGA THCA -0.078; TCGA UCEC -0.08 |
hsa-miR-149-5p | MR1 | 10 cancers: HNSC; KIRP; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA HNSC -0.057; TCGA KIRP -0.13; TCGA LUAD -0.082; TCGA LUSC -0.053; TCGA OV -0.1; TCGA PRAD -0.148; TCGA SARC -0.097; TCGA THCA -0.1; TCGA STAD -0.063; TCGA UCEC -0.157 |
Enriched cancer pathways of putative targets